DRUGS REPORTS

More documents

Recommendations

Info

Drugs Off-Patent Reports Drugs Off-Patent Reports ISSN 0793694X Year of Expiration - 2005 Drug OFF Generic Patent Patent Exclusivity Patent & Earliest 1999 Patent Name Holder Expiry Expiry Exclusivity Generic 2001 1 Marketer Trade Generic NAME Patent # DATE CODES DATE USD$ (Mil) Quinapril Accupril WLambert 4/10/05 5-747-504 Pamidronate DiNa Aredia Novartis 07/29/05 4-711-880 Retrovir Zidovudine Glaxo Wellcome Zithromax Pravachol Pfizer (Pliva) Zocor Simvastatin Merck & Co. 9/17/05 4-837-208 10/14/05 4-517-359 BMS 10/20/05 4-346-227 12/23/05 4-444-784 Lorabid Loracarbef E. Lilly 11/24/05 4-708-956 Zofran Lupron Depot-3 Lupron Depot-4 Lupron Depot Luprolide Acetate Luprolide Acetate Luprolide Acetate Azithromycin Pravastin sodium Ondansetron Glaxo- Wellcome TAP Pharm TAP Pharm TAP Pharm 06/25/05 4-695-578 07/03/05 4-677-191 M/D/YY U210 - 07/16/99 - I-158 04/10/05 357 386. 07/29/05 242 251 M/D/YY - - 09/17/05 127 157 M/D/YY - - 10/14/05 1080 1255. M/D/YY 10/20/05 1130 1210 M/D/YY U-59 I-128 12/23/05 1920 2090 M/D/YY - - 12/24/05 129 165 04/19/98 U-183 D-20 I-9 + I-151 - 03/07/00 07/03/05 4-677-191 05/30/00 07/03/05 4-677-191 CEFZIL Cefprozil BMS 11/28/05 4-520-022 Sporonox Itraconazole J & J 12/23/05 4-791-111 - NP - NS 06/25/05 510 550. 07/03/05 270 298 07/03/05 122 125 M/D/YY - - 07/03/05 255 264 M/D/YY U-4 11/28/05 358 390 11/28/05 195 238 NA = Not Applicable ODE = Orphan Drug Exclusivity NS = New Strength NCE = New Chemical Entity NE = New Active Salt or Ester NP = New Drug Product NDF = New Dosage Form NC = New Combination 2001 1 USA + EU Sales U = Code for Therapeutic Use still under Patent Protection I = Code for specific Indication under Exclusivity Protection D = New Dosing Schedule Drugs Off-Patent Reports 16 Over USD$ 100 million
Drugs Off-Patent Reports Drugs Off-Patent Reports ISSN 0793694X Year of Expiration - 2006 Drug OFF Generic Patent Patent Name Holder Marketer Patent Expiry Exclusivit y Expiry Patent & Exclusivit y Earliest Generic 1999 2001 1 Trade Generic NAME Patent # DATE CODES DATE USD$ (Mil) Proscar Finasteride Merck & Co. 6/19/06 4-760-071 6/19/97 NCE 06/19/06 255 000 GEMZAR Gemcitabine E Lilly 2/28/06 4-808-614 5/15/01 NCE 02/28/06 215 229 TIMOPTIC XE Timolol maleate Merck & Co. 08/29/06 4-861-769 M/D/YY 08/29/06 100 111 Ambien Zolpiderm Tartrate Searle Monsanto 10/21/06 4-382-938 12/16/97 U-74 NCE 10/21/06 535 705 [207] 4q K-DUR KCl S Plough 09/05/06 4-863-743 M/D/YY U-99 09/05/06 240 264 PAXIL Paroxitine HCl SKB 12/29/06 4-721-723 12/29/97 NCE U-12 12/29/06 1205 1374 Prempro- 14/14 Estrogen conjugated AHP Wyeth Ar 02/05/06 4-826-831 M/D/YY 02/05/06 460 498 4q = Fourth Quarter 2000 NA = Not Applicable ODE = Orphan Drug Exclusivity NS = New Strength NCE = New Chemical Entity NE = New Active Salt or Ester NP = New Drug Product NDF = New Dosage Form NC = New Combination 2001 1 USA + EU Sales U = Code for Therapeutic Use still I = Code for specific Indication D = New Dosing Schedule under Patent Protection under Exclusivity Protection Drugs Off-Patent Reports 17 Over USD$ 100 million
Page 1 and 2: Drugs Off-Patent Reports PHARMACEUT
Page 3 and 4: Drugs Off-Patent Reports A IAGIM Dr
Page 5 and 6: Drugs Off-Patent Reports Drugs Off-
Page 13: Drugs Off-Patent Reports Drugs Off-
Page 17 and 18: Drug OFF Generic Patent Patent Name
Page 21 and 22: Drugs Off-Patent Reports NASONEX Mo
Page 23: Drugs Off-Patent Reports % Market S

DRUGS REPORTS

Create successful ePaper yourself

Delete template?

Save as template?